+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peptide Microarray Market Size, Share & Trends Analysis Report By Type (Reagents, Services), Application (Disease Diagnostics, Protein Functional Analysis), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 5734500
Description Jump to:
The global peptide microarray market size is expected to reach USD 427.3 million by 2030, registering a CAGR of 6.18% from 2024 to 2030, according to a new report. The market is expected to witness a stable growth rate during the forecast period. The technique includes high throughput technologies in the area of clinical assays and proteomics. Peptide microarray can be analyzed through spectroscopy, mass spectrometry, and imaging via fluorescence. It has considerable applications in the field of medicine, pharmacology, and biology. It is one of the automated advanced technologies to collect a large volume of data from an experiment employed for therapeutic discoveries, disease diagnosis, and diagnostic technique development.

The method is employed to identify new drug targets. To detect the antigen present on the protein surface of bacteria, determination of Abs, immunogenic Identification, mapping of the epitope, biomarker validation, serum profiling, enzyme characterization, and HLA profiling are some of the applications of the peptide microarray. The use of peptide microarray for developing diagnostic tests is considered to be an important determinant of industry growth. According to research published in March 2021, peptide microarray can offer significant insights into the antigens for developing the COVID-19-based diagnostic test. Researchers used peptide microarrays to screen the samples for antibodies against the virus. Hence, the development of peptide microarray-based tests is expected to boost industry growth.

For instance, JPT Peptide Technologies commercializes peptide microarray for COVID-19 and infectious conditions at the retail price of USD 324. The technology can be used for immune detection and monitoring, biomarker discovery, and protein interaction validation. Key players are focusing on strategic initiatives to establish a strong distribution network across the globe. For instance, PEPperPRINT GmbH created its presence in the Asia Pacific regional market through distributors such as 4A Biotech Co., Ltd., Filgen, Inc., Tokyo Future Style, Inc., AbClon Inc., Tokyo Future Style Taiwan, Inc., Sciencewerke Co., Ltd., and TrendBio. The company adopted an indirect distribution strategy in the region. The strategy assisted the company to avoid the costs of regulatory compliance and customer acquisitions.

Peptide Microarray Market Report Highlights

  • The instruments type segment is relatively more mature than the services segment and held the largest share in 2023 due to the high number of pharma & biotech companies establishing in-house research stations for antibody-based research
  • The disease diagnostics application segment captured the largest revenue share in 2023 owing to the high incidence of infectious diseases in emerging markets. For instance, PEPperPRINT GmbH offers peptide microarray for over 32 infectious conditions
  • The pharmaceutical & biotechnology companies end-user segment held the maximum revenue share in 2023 due to the wide use of antibody characterization and validation of protein interactions
  • North America accounted for the largest share of the overall revenue in 2023 due to the well-established healthcare facilities in this region along with increased investment in the R&D sector
  • The rising awareness among healthcare professionals and patients about the early detection and treatment of chronic diseases also speeds up diagnostic capabilities and boosts the region's growth
  • Moreover, the increasing incidence of diseases, such as chronic and infectious diseases, is encouraging companies to enter the regional market


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Type Segment
1.2.2. Application Segment
1.2.3. End Use Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Peptide Microarrays Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing burden of chronic diseases
3.2.1.2. Technological advancements in diagnostic testing
3.2.1.3. Rising adoption of peptide microarrays
3.2.2. Market restraint analysis
3.2.2.1. Reimbursement issues
3.3. Peptide Microarrays Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Peptide Microarrays Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Peptide Microarrays Market Type Movement Analysis
4.3. Global Peptide Microarrays Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Instruments
4.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Reagents
4.5.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Services
4.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Peptide Microarrays Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Peptide Microarrays Market Application Movement Analysis
5.3. Global Peptide Microarrays Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Disease Diagnosis
5.4.1. Disease diagnosis market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Protein Functional Analysis
5.5.1. Protein functional analysis market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Antibody Characterization
5.6.1. Antibody characterization market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Drug Discovery
5.7.1. Drug discovery market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Peptide Microarrays Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Peptide Microarrays Market End Use Movement Analysis
6.3. Global Peptide Microarrays Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Hospitals & Clinics
6.5.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Diagnostic Centers
6.6.1. Diagnostic centers market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Peptide Microarrays Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamics
7.5.9.2. Competitive scenario
7.5.9.3. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. PEPperPRINT GmbH
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. RayBiotech, Inc.
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Creative Biolabs.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Aurora Biomed Inc.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Kinexus Bioinformatics Corporation
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Bio-Synthesis Inc.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Microarrays Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Arryait Corporation (ARYC).
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. JPT Peptide Technologies
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.10. Merck KGaA
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. Innopsys
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Nimble Therapeutics, Inc.
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global peptide microarray market, by region, 2018 - 2030 (USD Million)
Table 3 Global peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 4 Global peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 5 Global peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 6 North America peptide microarray market, by country, 2018 - 2030 (USD Million)
Table 7 North America peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 8 North America peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 9 North America peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 10 U.S. peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 11 U.S. peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 13 Canada peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 14 Canada peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 15 Canada peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 16 Mexico peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 17 Mexico peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 19 Europe peptide microarray market, by country, 2018 - 2030 (USD Million)
Table 20 Europe peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 21 Europe peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 22 Europe peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 23 Germany peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 24 Germany peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 25 Germany peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 26 UK peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 27 UK peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 28 UK peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 29 France peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 30 France peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 31 France peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 32 Italy peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 33 Italy peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 34 Italy peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 35 Spain peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 36 Spain peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 37 Spain peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 38 Denmark peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 39 Denmark peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 41 Sweden peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 42 Sweden peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 44 Norway peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 45 Norway peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 46 Norway peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific peptide microarray market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 49 Asia Pacific peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 50 Asia Pacific peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 51 China peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 52 China peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 53 China peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 54 Japan peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 55 Japan peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 56 Japan peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 57 India peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 58 India peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 59 India peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 60 South Korea peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 61 South Korea peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 62 South Korea peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 63 Australia peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 64 Australia peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 65 Australia peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 66 Thailand peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 67 Thailand peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 68 Thailand peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 69 Latin America peptide microarray market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 71 Latin America peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 72 Latin America peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 73 Brazil peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 74 Brazil peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 75 Brazil peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 76 Argentina peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 77 Argentina peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 78 Argentina peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 79 MEA peptide microarray market, by country, 2018 - 2030 (USD Million)
Table 80 MEA peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 81 MEA peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 82 MEA peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 83 South Africa peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 84 South Africa peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 85 South Africa peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 89 UAE peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 90 UAE peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 91 UAE peptide microarray market, by End Use, 2018 - 2030 (USD Million)
Table 92 Kuwait peptide microarray market, by type, 2018 - 2030 (USD Million)
Table 93 Kuwait peptide microarray market, by application, 2018 - 2030 (USD Million)
Table 94 Kuwait peptide microarray market, by End Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 Peptide microarray market: Market outlook
Fig. 5 Peptide microarray market: Segment outlook
Fig. 6 Peptide microarray market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 Peptide microarray market driver impact
Fig. 9 Peptide microarray market restraint impact
Fig. 10 Peptide microarray market: Type outlook and key takeaways
Fig. 11 Peptide microarray market: Type movement analysis
Fig. 12 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 Reagents microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 Services microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Peptide microarray market: Application outlook and key takeaways
Fig. 16 Peptide microarray market: Application movement analysis
Fig. 17 Disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Protein functional analysis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Antibody characterization market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 20 Drug discovery market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 21 Peptide microarray market: End Use outlook and key takeaways
Fig. 22 Peptide microarray market: End Use movement analysis
Fig. 23 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 24 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Global peptide microarray market: Regional outlook and key takeaways
Fig. 28 Global peptide microarray market: Regional movement analysis
Fig. 29 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Key country dynamics
Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Key country dynamics
Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Key country dynamics
Fig. 35 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Key country dynamics
Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Key country dynamics
Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Key country dynamics
Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Key country dynamics
Fig. 44 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Key country dynamics
Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • PEPperPRINT GmbH
  • RayBiotech, Inc.
  • Creative Biolabs.
  • Aurora Biomed Inc.
  • Kinexus Bioinformatics Corporation
  • Bio-Synthesis Inc.
  • Microarrays Inc.
  • Arryait Corporation (ARYC).
  • JPT Peptide Technologies
  • Merck KGaA
  • Innopsys
  • Nimble Therapeutics, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedJuly 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 288.3 Million
Forecasted Market Value ( USD ) by 2030 $ 427.3 Million
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Microarray Market by Product & Service, Type, Application, End User - Global Forecast 2025-2030 - Product Image

Microarray Market by Product & Service, Type, Application, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
DNA Microarray Market Size, Share & Trends Analysis Report By Type (Complementary DNA Microarrays, Oligonucleotide DNA Microarrays), By Application (Gene Expression Analysis, Genotyping), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

DNA Microarray Market Size, Share & Trends Analysis Report By Type (Complementary DNA Microarrays, Oligonucleotide DNA Microarrays), By Application (Gene Expression Analysis, Genotyping), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Microarray Global Market Report 2024 - Product Image

Microarray Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Tissue Microarray - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Tissue Microarray - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 111 Pages
  • Global
From
DNA Microarray Market Report and Forecast 2024-2032 - Product Image

DNA Microarray Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From

About the Peptide Microarray Market

The Peptide Microarray market is a subset of the biotechnology industry that focuses on the development and production of peptide microarrays. These microarrays are used to detect and measure the presence of peptides in a sample, and are used in a variety of research and clinical applications. Peptide microarrays are used to identify biomarkers, measure drug efficacy, and study protein-protein interactions. They are also used to study the effects of post-translational modifications on protein function. The Peptide Microarray market is highly competitive, with a number of companies offering products and services. Companies in the market include Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.